Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R) 2020-11-09 18:22
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim 2020-11-09 18:07
PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period 2020-11-05 21:00
Gracell Biotechnologies Announces Two Oral Presentations at the ASH Annual Meeting and Exposition 2020 2020-11-05 11:52
Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation 2020-11-04 20:00
Great Bay Bio Announces Its First AI-enabled Bioprocessing Platform-Klone 4.0, Reducing Cell Line Development Time and Cost by Up to 80% 2020-11-02 22:00
Senhwa Announces Multiple IND application submissions to U.S. FDA for Silmitasertib as a Potential Treatment for COVID-19 2020-11-02 22:00
CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates 2020-11-02 19:00
Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development 2020-11-02 08:27
TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000 2020-11-02 07:30
Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide 2020-10-29 20:00
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center 2020-10-29 08:38
Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies 2020-10-28 21:00
Genome & Company announces first patient dosed in Phase 1/1b study of GEN-001, an immuno-oncology microbiome therapeutic, in combination with avelumab 2020-10-27 21:00
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2020-10-27 20:05
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study 2020-10-27 10:03
Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis 2020-10-26 19:40
PharmAbcine to participate at BIO-Europe 2020 2020-10-23 20:00
Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement 2020-10-22 14:00
Samsung Biologics' strategic business operations continue to support strong third quarter earnings 2020-10-21 19:00
1 116 117 118 119 120 222